2003 Fall Seminar Series

September 11, 2003

Martin Rosenberg, Ph.D.
Promega Corporation
From Genomics to Medicines:  Opportunities and Hurdles

September 25, 2003

Paul A. Rota, Ph.D.
Centers for Disease Control & Prevention
Measles Virus Section
SARS and Nipah Virus

October 9, 2003

Chad Mirkin, Ph.D.
Institute for Nanotechnology
Northwestern University
Nanoparticle-Based Biodiagnostics: Toward PCR-less Detection Methods

October 16, 2003

Vincent Fischetti, Ph.D.
Bacterial Pathogenesis & Immunology
The Rockefeller University
Killing Pathogenic Bacteria Like Never Before

October 23, 2003

Connie Schmaljohn, Ph.D.
US Army Medical Research
Institute of Infectious Diseases 
Multiagent DNA Vaccines for Highly Pathogenic Viruses

November 6, 2003

Rona Hirschberg, Ph.D.
National Institutes of Health
NIAID
Cancelled

November 13, 2003

Bernard Moss, M.D., Ph.D.
National Institutes of Health, NIAID
Laboratory of Viral Diseases
Poxviruses: For Good and Evil

December 4, 2003

Robert M. Krug, Ph.D.
Institute for Cellular & Molecular Biology
University of Texas at Austin
New Targets for Antivirals Against Influenza A Virus, a Constantly Re-emerging Human Pathogen

December 11, 2003

Nancy D. Connell, Ph.D.
International Center for Public Health
New Jersey Medical School
Plague and Tularemia: Virulence Factors Dictated by Lifestyle

December 18, 2003

John A. Young, Ph.D.
University of Wisconsin-Madison
McArdle Laboratory for Cancer Research
Cellular Factor Requirement for HIV-1 Uncoating Revealed by a Cell-free System